Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017

Electron micrograph of hepatitis B virus. Credit: Centers for Disease Control and Prevention
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

The World Health Organization's latest report identifies the condition as a grave that needs an "urgent response."

Hepatitis killed 1.34 million people in 2015, a toll roughly in-line with HIV and tuberculosis.

But in contrast to HIV and TB, hepatitis deaths are increasing, WHO said, recording a 22 percent mortality rise from 2000 to 2014.

Hepatitis is often symptom free, but types B and C can trigger liver cirrhosis and cancer if untreated.

Lack of awareness among those infected is driving the virus's spread.

For hepatitis B—which is spread through bodily fluids like blood and semen—only nine percent of those infected know their status.

And for hepatitis C, primarily spread through blood, just 20 percent of those infected are aware of their condition.

Lack of access to testing and treatment leaves "millions of people at risk of a slow progression to , cancer and death", WHO said in a statement.

The hepatitis B problem is most acute in the WHO's Western Pacific Region, which includes China, Malaysia and southeast Asia. An estimated 115 million people in the region have the virus.

Second worst is Africa, with 60 million hepatitis B cases.

An effective vaccine exists for hepatitis B.

WHO's latest data shows that hepatitis C—for which there is no vaccine—is most commonly spread through unsafe injections, notably among drug users.

Europe and the eastern Mediterranean region are afflicted with the most hepatitis C cases at 14 million and 15 million respectively.

WHO is trying to ramp up the global hepatitis response, aiming to treat some 80 percent of sufferers worldwide by 2030.

Explore further: FDA approves hep C drugs for kids 12 and older

Related Stories

FDA approves hep C drugs for kids 12 and older

April 7, 2017
(HealthDay)—The U.S. Food and Drug Administration has approved two drugs to treat hepatitis C infection in children aged 12 and older.

Hepatitis B and C may be linked to increased risk of Parkinson's disease

March 29, 2017
The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy ...

Drug for one hepatitis type may activate another: watchdog

December 2, 2016
Drugs against one type of hepatitis may activate another, sometimes with fatal consequences, Europe's medicines watchdog warned on Friday.

Hepatitis C tied to increased risk of Parkinson's

December 24, 2015
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the December 23, 2015, online issue of Neurology, the medical journal of the American Academy ...

Experts call for stepped-up hepatitis battle

July 24, 2014
The world can beat the cancer-causing disease hepatitis if it raises its game, but treatment programmes need to go hand in hand with those tackling the likes of HIV, experts said Thursday.

Chinese researchers report successful hepatitis E vaccine

March 4, 2015
(HealthDay)—A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers.

Recommended for you

Zika may hijack mother-fetus immunity route

November 14, 2018
To cross the placenta, Zika virus may hijack the route by which acquired immunity is transferred from mother to fetus, new research suggests.

Maternally acquired Zika immunity can increase dengue disease severity in mouse pups

November 14, 2018
To say that the immune system is complex is an understatement: an immune response protective in one context can turn deadly over time, as evidenced by numerous epidemiological studies on dengue infection, spanning multiple ...

New research aims to help improve uptake of hepatitis C testing

November 14, 2018
New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the hepatitis C Virus (HCV).

Discovery suggests new route to fight infection, disease

November 14, 2018
New research reveals how a single protein interferes with the immune system when exposed to the bacterium that causes Legionnaires' disease, findings that could have broad implications for development of medicines to fight ...

Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies

November 13, 2018
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...

Scientists illuminate causes of hepatitis B virus-associated acute liver failure

November 13, 2018
National Institutes of Health scientists and their collaborators found that hepatitis B virus (HBV)-associated acute liver failure (ALF)—a rare condition that can turn fatal within days without liver transplantation—results ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.